methylprednisolone hemisuccinate has been researched along with Nausea in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierbrauer, KS; Caruso, MC; Daugherty, MC; Falcone, RA; Geis, GL; Moody, SM | 1 |
| Kaliciak-Kempińska, A; Mazur-Chłodek, L | 1 |
| Aydin, S; Dührsen, U; Nückel, H | 1 |
| Cook, RJ | 1 |
| Becker, A; Debrix, I; Milleron, B; Puteaux, S | 1 |
| Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T | 1 |
| Cook, RJ; Willan, AR | 1 |
| Brigden, ML; Erlichman, C; Geggie, P; Osoba, D; Pater, JL; Rusthoven, JJ; Willan, AR; Wilson, KS | 1 |
| Erlichman, C; Levitt, M; Osoba, D; Pater, JL; Willan, AR | 1 |
4 trial(s) available for methylprednisolone hemisuccinate and Nausea
| Article | Year |
|---|---|
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2007 |
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting | 1995 |
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy.
Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Nausea; Random Allocation; Vomiting | 1988 |
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
Topics: Antineoplastic Agents; Anxiety; Gastrointestinal Diseases; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Sleep Stages; Vomiting | 1986 |
5 other study(ies) available for methylprednisolone hemisuccinate and Nausea
| Article | Year |
|---|---|
Lessons learned from administration of high-dose methylprednisolone sodium succinate for acute pediatric spinal cord injuries.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Hyperglycemia; Infant; Infant, Newborn; Male; Methylprednisolone Hemisuccinate; Nausea; Neuroprotective Agents; Retrospective Studies; Spinal Cord Injuries | 2017 |
[Side effects during treatment with Solu-Medrol for optic neuritis in the course of MS].
Topics: Adult; Female; Headache; Humans; Leukocyte Disorders; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Nausea; Neuroprotective Agents; Optic Neuritis | 2003 |
Interim analyses in 2 x 2 crossover trials.
Topics: Antiemetics; Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Mathematics; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Research Design | 1995 |
[Efficacy of the granisetron/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey].
Topics: Antiemetics; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Drug Therapy, Combination; Female; Granisetron; Health Surveys; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Prospective Studies; Serotonin Receptor Agonists; Vomiting | 1995 |
Design considerations in crossover trials with a single interim analysis and serial patient entry.
Topics: Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Linear Models; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Randomized Controlled Trials as Topic; Time Factors | 1996 |